SPL 1.08% 9.4¢ starpharma holdings limited

Astra Zeneca Quarterly, page-17

  1. 34 Posts.
    lightbulb Created with Sketch. 28
    Might this be the significantly expanded clinical program for AZD0466 we’ve all been waiting for?

    https://clinicaltrials.gov/ct2/show/NCT04865419

    Estimated enrollment: 160 participants
    Estimated study start date: April 30, 2021
    Estimated study completion date: October 31, 2024
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.